Credit Agricole’s GSK GSK Stock Holding History

Credit Agricole’s Portfolio GSK Stock Details GSK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q3	–	Sell	-51,680	Closed	-$2.8M	–	1631
2016 Q2	$2.8M	Buy	+51,680	New	+$2.72M	0.01%	759

Other funds holding GSK

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

JEST

JTC Employer Solutions Trustee St Helier, Jersey $1.25B AUM 41.83% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

Credit Agricole's GSK Position: Q2 2026 in Review

Credit Agricole increased its GSK (GSK) stake by 16% in Q2 2026, buying an estimated $984K and bringing the position to 132,780 shares worth $6.96M. The position accounts for 0.01% of the portfolio, ranked #586.

Credit Agricole first reported a position in GSK in Q4 2014 and has held it in 30 quarters since. 1,040 funds tracked by Wall St. Rank hold GSK as of Q2 2026.

Credit Agricole held 132,780 shares of GSK worth $6.96M as of Q2 2026.
Credit Agricole bought 18,600 GSK shares in Q2 2026, an estimated $984K.
GSK made up 0.01% of Credit Agricole's portfolio in Q2 2026, its #586 holding.
Credit Agricole first reported a position in GSK in Q4 2014 and has held it in 30 quarters since.
1,040 funds tracked by Wall St. Rank held GSK as of Q2 2026.

Based on Credit Agricole's 13F filing for Q2 2026, filed 14 Aug 2026.